Dr. Reddy's Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was INR 53,197 million compared to INR 49,296 million a year ago. Net income was INR 7,065 million compared to INR 198 million a year ago. Basic earnings per share from continuing operations was INR 42.58 compared to INR 1.19 a year ago. Diluted earnings per share from continuing operations was INR 42.48 compared to INR 1.19 a year ago.
For the nine months, sales was INR 160,023 million compared to INR 142,438 million a year ago. Net income was INR 22,693 million compared to INR 13,614 million a year ago. Basic earnings per share from continuing operations was INR 136.82 compared to INR 82.08 a year ago. Diluted earnings per share from continuing operations was INR 136.48 compared to INR 81.85 a year ago.